Propanc Biopharma, Inc. Common Stock
Symbol: PPCB (NASDAQ)
1.70
▼ (-7.38%) -0.135
Company Description:
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Key Stats
- Today's Open: $1.77
- Today's High: $1.87
- Today's Low: $1.695
- Today's Volume: 145.68K
- Yesterday Close: $1.83
- Yesterday High: $1.92
- Yesterday Low: $1.8
- Yesterday Volume: 69.46K
- Last Min Volume: 1
- Last Min High: $1.695
- Last Min Low: $1.695
- Last Min VWAP: $1.695
Company Profile
- Name: Propanc Biopharma, Inc. Common Stock
- Website: https://www.propanc.com
- Listed Date: 2012-06-15
- Location: CAMBERWELL, VICTORIA, C3
- Market Status: Active
- CIK Number: 0001517681
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $23.08M
- Round Lot: 100
- Outstanding Shares: 12.61M
- Asset Type: CS
RECENT FILINGS FOR PPCB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | 10-K | View |
| 2025-08-19 | 8-K | View |
| 2025-08-19 | SCHEDULE 13G | View |
| 2025-08-18 | 424B3 | View |
| 2025-08-18 | 424B4 | View |
| 2025-08-14 | CERT | View |
| 2025-08-13 | EFFECT | View |
| 2025-08-13 | 8-A12B | View |
| 2025-08-13 | 8-K | View |
| 2025-08-12 | CORRESP | View |
| 2025-08-12 | CORRESP | View |
| 2025-07-31 | CORRESP | View |
| 2025-07-31 | CORRESP | View |
| 2025-07-30 | 8-K | View |
| 2025-07-29 | CORRESP | View |
| 2025-07-29 | CORRESP | View |
| 2025-07-28 | S-1/A | View |
| 2025-07-24 | CORRESP | View |
| 2025-07-24 | CORRESP | View |
| 2025-07-22 | 8-K | View |
Latest News on PPCB